Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

510(k) required for Utah Medical Products' Cordguard II:

This article was originally published in Clinica

Executive Summary

The US CDRH has advised Utah Medical Products (US) that it will have to submit new 510(k) premarketing submission for its new version of Cordguard I. Utah Medical had intended to begin sales of the Cordguard II device later this month but decided to check with the agency that the modified device did not require regulatory clearance. The CRDH informed the company on September 20th that it needs formal documentation that the device is substantially equivalent to the original device. Cordguard II has been designed to reduce clinician exposure to potentially infected blood splatters while collecting neonatal blood samples for diagnosis.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel